Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabrielle Caron

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Medical Economics|May 2, 2023
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United StatesMaryia Zhdanava, Amanda Teeple, Dominic Pilon, et al.
Current Medical Research and Opinion|July 26, 2023
Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insuranceAmanda Teeple, Maryia Zhdanava, Dominic Pilon, et al.
International Journal of Clinical Pharmacy|May 19, 2023
Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal studyMark Alberts, Maryia Zhdanava, Dominic Pilon, et al.
Advances in Therapy|March 22, 2023
Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial FibrillationMark Alberts, Maryia Zhdanava, Dominic Pilon, et al.
Journal of Neurosurgery. Pediatrics|March 28, 2025
Healthcare resource utilization for the management of neonatal head shape deformities: a propensity-matched analysis of AI-assisted and conventional approachesJimin Shin, Gabrielle Caron, Petronella Stoltz, et al.
Advances in Therapy|February 24, 2023
Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal StudyMark Alberts, Maryia Zhdanava, Dominic Pilon, et al.
Current Medical Research and Opinion|August 17, 2023
Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapyMark J Alberts, Maryia Zhdanava, Dominic Pilon, et al.
Journal of Market Access & Health Policy|September 24, 2024
Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based AnalysisMichael Ingham, Hela Romdhani, Aarti Patel, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 31, 2023
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1Prina Donga, Bruno Emond, Carmine Rossi, et al.
Journal of Neurosurgery. Pediatrics|January 22, 2026
Diagnostic AI model deployment in neurosurgery: lessons learnedMarkus J Bookland, Ross Bernstein, Gabrielle Caron, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Medical Economics|May 2, 2023
Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United StatesMaryia Zhdanava, Amanda Teeple, Dominic Pilon, et al.
Current Medical Research and Opinion|July 26, 2023
Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insuranceAmanda Teeple, Maryia Zhdanava, Dominic Pilon, et al.
International Journal of Clinical Pharmacy|May 19, 2023
Venous thromboembolism recurrence among one-and-done direct oral anticoagulant users: a retrospective longitudinal studyMark Alberts, Maryia Zhdanava, Dominic Pilon, et al.
Advances in Therapy|March 22, 2023
Ischemic Stroke and Systemic Embolism Among One-and-Done Direct Oral Anticoagulant Users with Non-valvular Atrial FibrillationMark Alberts, Maryia Zhdanava, Dominic Pilon, et al.
Journal of Neurosurgery. Pediatrics|March 28, 2025
Healthcare resource utilization for the management of neonatal head shape deformities: a propensity-matched analysis of AI-assisted and conventional approachesJimin Shin, Gabrielle Caron, Petronella Stoltz, et al.
Advances in Therapy|February 24, 2023
Venous Thromboembolism Recurrence Among Patients Who Abandon Oral Anticoagulant Therapy in the USA: A Retrospective Longitudinal StudyMark Alberts, Maryia Zhdanava, Dominic Pilon, et al.
Current Medical Research and Opinion|August 17, 2023
Ischemic stroke and systemic embolism among patients with non-valvular atrial fibrillation who abandon oral anticoagulant therapyMark J Alberts, Maryia Zhdanava, Dominic Pilon, et al.
Journal of Market Access & Health Policy|September 24, 2024
Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based AnalysisMichael Ingham, Hela Romdhani, Aarti Patel, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 31, 2023
Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1Prina Donga, Bruno Emond, Carmine Rossi, et al.
Journal of Neurosurgery. Pediatrics|January 22, 2026
Diagnostic AI model deployment in neurosurgery: lessons learnedMarkus J Bookland, Ross Bernstein, Gabrielle Caron, et al.
Pageof 2